4-73740952-T-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000584.4(CXCL8):​c.64+230T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.444 in 151,958 control chromosomes in the GnomAD database, including 15,055 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.44 ( 15055 hom., cov: 32)

Consequence

CXCL8
NM_000584.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.324

Publications

74 publications found
Variant links:
Genes affected
CXCL8 (HGNC:6025): (C-X-C motif chemokine ligand 8) The protein encoded by this gene is a member of the CXC chemokine family and is a major mediator of the inflammatory response. The encoded protein is commonly referred to as interleukin-8 (IL-8). IL-8 is secreted by mononuclear macrophages, neutrophils, eosinophils, T lymphocytes, epithelial cells, and fibroblasts. It functions as a chemotactic factor by guiding the neutrophils to the site of infection. Bacterial and viral products rapidly induce IL-8 expression. IL-8 also participates with other cytokines in the proinflammatory signaling cascade and plays a role in systemic inflammatory response syndrome (SIRS). This gene is believed to play a role in the pathogenesis of the lower respiratory tract infection bronchiolitis, a common respiratory tract disease caused by the respiratory syncytial virus (RSV). The overproduction of this proinflammatory protein is thought to cause the lung inflammation associated with csytic fibrosis. This proinflammatory protein is also suspected of playing a role in coronary artery disease and endothelial dysfunction. This protein is also secreted by tumor cells and promotes tumor migration, invasion, angiogenesis and metastasis. This chemokine is also a potent angiogenic factor. The binding of IL-8 to one of its receptors (IL-8RB/CXCR2) increases the permeability of blood vessels and increasing levels of IL-8 are positively correlated with increased severity of multiple disease outcomes (eg, sepsis). This gene and other members of the CXC chemokine gene family form a gene cluster in a region of chromosome 4q. [provided by RefSeq, May 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.486 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000584.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CXCL8
NM_000584.4
MANE Select
c.64+230T>G
intron
N/ANP_000575.1
CXCL8
NM_001354840.3
c.64+230T>G
intron
N/ANP_001341769.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CXCL8
ENST00000307407.8
TSL:1 MANE Select
c.64+230T>G
intron
N/AENSP00000306512.3
CXCL8
ENST00000401931.2
TSL:1
c.64+230T>G
intron
N/AENSP00000385908.1
CXCL8
ENST00000696131.1
n.*171T>G
non_coding_transcript_exon
Exon 1 of 4ENSP00000512424.1

Frequencies

GnomAD3 genomes
AF:
0.444
AC:
67395
AN:
151840
Hom.:
15050
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.492
Gnomad AMI
AF:
0.423
Gnomad AMR
AF:
0.368
Gnomad ASJ
AF:
0.383
Gnomad EAS
AF:
0.392
Gnomad SAS
AF:
0.378
Gnomad FIN
AF:
0.404
Gnomad MID
AF:
0.332
Gnomad NFE
AF:
0.450
Gnomad OTH
AF:
0.439
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.444
AC:
67446
AN:
151958
Hom.:
15055
Cov.:
32
AF XY:
0.438
AC XY:
32569
AN XY:
74286
show subpopulations
African (AFR)
AF:
0.492
AC:
20389
AN:
41438
American (AMR)
AF:
0.368
AC:
5614
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
0.383
AC:
1327
AN:
3468
East Asian (EAS)
AF:
0.391
AC:
2016
AN:
5158
South Asian (SAS)
AF:
0.378
AC:
1822
AN:
4820
European-Finnish (FIN)
AF:
0.404
AC:
4262
AN:
10546
Middle Eastern (MID)
AF:
0.333
AC:
98
AN:
294
European-Non Finnish (NFE)
AF:
0.450
AC:
30605
AN:
67956
Other (OTH)
AF:
0.440
AC:
927
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1914
3828
5742
7656
9570
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
634
1268
1902
2536
3170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.453
Hom.:
2411
Bravo
AF:
0.446
Asia WGS
AF:
0.373
AC:
1296
AN:
3474

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
5.5
DANN
Benign
0.60
PhyloP100
0.32
PromoterAI
0.0026
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2227307; hg19: chr4-74606669; API